Astellas Pharma, Sanofi-aventis Japan to Co-promtoe Myslee Tablet, Hypnotic Drug.Tokyo, Japan, Dec 16, 2005 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Astellas Pharma Astellas Pharma Inc. (アステラス製薬株式会社 and sanofi-aventis Group Japan (sanofi-aventis Japan) jointly announced on December 16 that they have agreed to jointly promote Myslee Tablets 5mg/10mg (zolpidem tartrate zol·pi·dem tartrate n. A nonbenzodiazepine hypnotic drug used to treat insomnia. zolpidem tartrate Ambien, Ambien CR, Stilnoct (UK), Tovalt ODT Pharmacologic class: Imidazopyridine ), ethical drugs for the treatment of insomnia, beginning in April 2006. Myslee, which is made of zolpidem tartrate, can provide a natural and restful rest·ful adj. 1. Affording, marked by, or suggesting rest; tranquil. See Synonyms at comfortable. 2. Being at rest; quiet. rest sleep to patients with insomnia. Iinitially launched in France in 1988, it is currently marketed in about 100 countries worldwide under the trade names of Ambien and Stilnox. In Japan, ex-Fujisawa Pharmaceutical began marketing the product in December 2000. Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion